MTIP

GROWTH CAPITAL DECISIONS – AN INTERVIEW WITH OUR CO-FOUNDER & MANAGING PARTNER DR CHRISTOPH KAUSCH RAHEL HAFNER RECEIVES CERTIFICATE IN ESG INVESTING BY CFA INSTITUTE Rahel Hafner Receives Certificate in ESG Investing WHAT MAKES A GREAT FOUNDER/INVESTOR RELATIONSHIP? Interview with the CEO and Co-Founder Kai Eberhardt of our portfolio company Oviva MTIP’S HEALTHCARE CLINIC 2022 This year's HealthCare Clinic was held under the motto: "Surfing the Healthtech Waves of Change"

CHRISTOPH KAUSCH SELECTED BY REAL DEALS AS MOST INFLUENTIAL FOR 2022 Christoph Kausch named by Real Deals most influential for 2022 MTIP LEADS €17 MILLION FINANCING ROUND IN VIRTUAL FERTILITY CLINIC APRICITY MTIP LEADS THE €20 MILLION GROWTH FINANCING ROUND IN LYNXCARE Largest capital round ever in digital health in Belgium PIONEERING THE USE OF MACHINE LEARNING ALGORITHMS TO TURBO-CHARGE DRUG DEVELOPMENT Intelligencia revolutionizes drug development THE PSYCHOLOGY OF DECISION MAKING What makes a good investor? REVOLUTIONIZING MEDICAL TRIAGE WITH ARTIFICIAL INTELLIGENCE Mediktor's solution for medical triage MTIP CLOSES SECOND HEALTHTECH GROWTH FUND ABOVE TARGET WITH $250M OF COMMITMENTS MTIP Fund II is closed! CYNERIO NOW! – A NEW IOT CYBERSECURITY SOLUTION FOR SMALL HOSPITALS AND CLINICS Cynerio's new product Cynerio Now! MTIP INVESTS IN MEDIKTOR New investment in Mediktor SFDR ART 8 OR ART 9? WHAT’S THE DIFFERENCE? SFDR: getting the terminology right MTIP PARTICIPATES IN OVIVA’S NEW $80M SERIES C FUNDING Oviva raises $80 million financing round MTIP INVESTS IN INTELLIGENCIA TO REDUCE THE RISK OF CLINICAL RESEARCH THROUGH ARTIFICIAL INTELLIGENCE